Experts, Advocates and Patients Call Release of UK QMUL PACE Data “A Gamechanging Win for People with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

FOR IMMEDIATE RELEASE:  Monday, September 12, 2016

CONTACT: Brett Abrams | +1-516-841-1105 | [email protected]

Experts, Advocates and Patients Call Release of UK QMUL PACE Data “A Gamechanging Win for People with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome”

Last week, Queen Mary University of London (QMUL) released data from its controversial PACE study on myalgic encephalomyelitis / chronic fatigue syndrome. The data release came after five years of pressure from patients and scientists who questioned the study’s claim that graded exercise and cognitive behavioral therapy were effective treatments for patients with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS).

The PACE trial has attracted mounting criticism in recent months from scientists, including a group of over 40 who said in an open letter to The Lancet, the journal that published the original paper, that PACE’s flaws “have no place in published research”.  In August, a UK tribunal ordered the release.  The following experts and advocates in the US and the UK responded to the release of the data.

Professor Jonathan Edwards of University College London, one of the letter’s signatories said:  

“The new analysis of the PACE trial appears to confirm the consensus view that CBT and graded exercise therapy were associated with a mild placebo effect.”

Dr. David Tuller, a journalist and public-health expert at the University of California-Berkeley who had been publicly critical of the trial added:

“Let’s be clear. These findings are really much worse than those presented in published, ‘peer-reviewed’ papers. If these were the best findings for $8 million, then PACE really will not survive legitimate scrutiny.”

Jennifer Brea, co-founder of #MEAction explained:

“The release of data from Queen Mary University of London’s PACE study into Myalgic Encephalomyelitis proves that graded exercise and cognitive behavioral therapy were never effective treatments for those suffering from ME.  The more than 1 million people that suffer from ME in the United States need real research into the causes of and potential treatments for this horrific disease, and we hope that the release of this data proves once and for all that this research is long overdue.”

LA Cooper, of #MEAction Network in the United Kingdom added:

“We are thrilled with the long-awaited outcome. The only way forward to ensure we better understand this disease and discover adequate treatments is through strong, trustworthy science. We believe that the release of the data is a huge step in the right direction.”

An analysis published Wednesday by the trial’s own authors states that just 21% of patients found improvement with graded exercise, as compared to the 61% they originally reported in The Lancet. Critics believe that when the data is independently analyzed, it will show that exercise has no positive benefit.  Graded exercise is a commonly prescribed treatment for ME/CFS but many patients and researchers state that it can make symptoms worse, sometimes permanently.

A petition led by #MEAction with over 12,000 signatures was presented at the tribunal as evidence of the level of public interest in data release. Over two dozen patients’ charities in 14 countries called on PACE’s authors to release their data for independent reanalysis. Queen Mary University spent over £200,000 on legal fees on a tribunal appeal to try to prevent the data’s release.


For more information about Myalgic Encephalomyelitis:
http://meaction.net/about/what-is-me/

For more information about the PACE trial:

http://meaction.net/2016/09/09/qmul-releases-pace-data/

For more information, or to speak with someone from #MEAction about the disease or the PACE trial, please contact Brett Abrams at +1-516-841-1105 or by email at [email protected].

# # # # #

Facebook
Twitter
WhatsApp
Email

Latest News

DHSC released a new progress Report

DHSC has released an update on the progress of the work underway to support the development of a Delivery Plan on Myalgic Encephalomyelitis / Chronic Fatigue. This is dated from December 2022.You can read the full report using the link below: DHSC Information Bulletin Dec 22 FINAL MECFS updated

Read More »
Gold fireworks lighting up over a black background. The words, TOP HITS 2022 is in the center in white lettering. the words: #MEAction accomplished a lot last year is undernether with the #MEAction logo

Let’s Look at #MEAction’s Top Hits from 2022

As we ring in the new year, it is a wonderful time to reflect on how much #MEAction accomplished in a very busy and exciting 2022! There are so many wins to share, so we decided to narrow down the list to our TOP HITS! ——————- #MILLIONSMISSING 2022: * Bringing together the powerful Virtual #MillionsMissing

Read More »
A photo from Millions Missing Scotland of a group of 20 protestors outside the Scottish Parliament. They’re looking serious and holding signs that say Millions Missing, and a pledge signed by MSPs. Many are wearing red ME Action t-shirts. A yellow icon of a person is overlaid next to them with an arrow pointing to it and the words ‘Could it be your MSP?’ A red banner along the bottom says ‘Share your story and ask your MSPs to stand up for people with ME.’

Ask your MSPs to stand up for people with ME

Sue Webber MSP’s motion about ME will be debated in the Scottish Parliament on Thursday 2nd February – and your MSPs should be there! The motion calls on the Scottish Parliament to recognise the outcomes and recommendations of the stakeholder report on ME, including education of healthcare professionals and development of specialist services. We’re pleased

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top